What does Inhibrx Biosciences, Inc. do?
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, which is in phase 1, a tetravalent therapeutic candidate targeting death-receptor 5 to treat…
What is Inhibrx Biosciences, Inc.'s P/E and P/B ratio?
Inhibrx Biosciences, Inc. has a P/E ratio of -10.9 and a P/B ratio of -26.98.
What is Inhibrx Biosciences, Inc.'s debt-to-equity ratio?
Inhibrx Biosciences, Inc. has a debt-to-equity ratio of 13.39.
How much does Inhibrx Biosciences, Inc. owe compared with what it owns?
Inhibrx Biosciences, Inc. owes $1.34 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Inhibrx Biosciences, Inc.'s Positivity rank?
Inhibrx Biosciences, Inc. is ranked #6,682 of 6,774 companies globally and #3,918 of 4,000 in United States on PositoAI, with a Positivity Score of -45,090.
Does Inhibrx Biosciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Inhibrx Biosciences, Inc..
Where can I read the latest news about Inhibrx Biosciences, Inc.?
Recent headlines about Inhibrx Biosciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Inhibrx Biosciences, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Inhibrx Biosciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.